TYR
Tyrosinase
As of the edition of 20 October 2026, TYR (tyrosinase, UniProt P14679) has 4 drugs tested at it and 3 companies on the list, 1 on route A and 2 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P14679
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- In more than one place
- Solved structures
- 1
- Disease areas
- Skin and connective tissue
- Registered trials of its drugs
- 3
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 3 |
| Stopped | 1 |
| Total | 4 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Avobenzone | Marketed | Phase 1 | none listed |
| Arbutin | Stopped | Phase 3 | none listed |
| Mequinol | Marketed | No phase stated | none listed |
| Monobenzone | Marketed | No phase stated | none listed |
4 of 4 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 1 |
| Route B | 2 |
| Total on the list | 3 |
| Company | Route |
|---|---|
| Bausch Health | Route B |
| Johnson & Johnson | Route B |
| Azidus Brasil | Route A |
The other 0 companies at TYR
In the product3 companies in all; 0 are not named here, and no score is.
See the 3 companies at TYR, ranked, with the facts behind eachRequest access. Nothing is shown until you do.